Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial. [PDF]
EClinicalMedicine, 2020 Abarca K +16 more
europepmc +1 more source
Comparison Between Simple Batch and Fed-Batch Bioreactor Cultivation of Recombinant BCG. [PDF]
PharmaceuticsMendes S +6 more
europepmc +1 more source
Enhanced Glycosylation Caused by Overexpression of Rv1002c in a Recombinant BCG Promotes Immune Response and Protects against Mycobacterium tuberculosis Infection. [PDF]
Vaccines (Basel)Weng S +7 more
europepmc +1 more source
Recombinant BCG vaccine expressing multistage antigens of Mycobacterium tuberculosis provides long-term immunity against tuberculosis in BALB/c mice. [PDF]
Hum Vaccin ImmunotherFang D +9 more
europepmc +1 more source
Robust Immune Response and Protection against Lethal Pneumococcal Challenge with a Recombinant BCG-PspA-PdT Prime/Boost Scheme Administered to Neonatal Mice. [PDF]
Vaccines (Basel)Trentini MM +5 more
europepmc +1 more source
Mucosal recombinant BCG vaccine induces lung-resident memory macrophages and enhances trained immunity via mTORC2/HK1-mediated metabolic rewiring. [PDF]
J Biol ChemPeng X +8 more
europepmc +1 more source
Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection against Tuberculosis. [PDF]
Mol Ther, 2018 Ahn SK +6 more
europepmc +1 more source
Early pneumococcal clearance in mice induced by systemic immunization with recombinant BCG PspA-PdT prime and protein boost correlates with cellular and humoral immune response in bronchoalveolar fluids (BALF). [PDF]
Vaccine X, 2020 Goulart C +4 more
europepmc +1 more source
Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity. [PDF]
Front Immunol, 2018 Soto JA +7 more
europepmc +1 more source